You are here

  • Home
  • Archive
  • Volume 6, Issue 11
  • Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model

Article metrics

Article menu

Download PDFPDF

XML
Health economics
Research
Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201815115140
Feb 2018847822
Mar 201813813845
Apr 2018656527
May 2018858622
Jun 2018818123
Jul 2018737335
Aug 2018848430
Sep 2018999929
Oct 2018747423
Nov 2018868642
Dec 2018878729
Jan 2019585836
Feb 2019454723
Mar 2019585928
Apr 2019606047
May 2019525222
Jun 2019565522
Jul 2019939038
Aug 2019575525
Oct 2019938827
Nov 201910810033
Dec 2019626015
Jan 2020726623
Feb 2020696728
Mar 2020626229
May 2020262515
Jun 2020383417
Jul 2020373517
Aug 2020312311
Sep 2020533522
Oct 2020484214
Nov 2020573932
Dec 2020574114
Jan 2021555416
Feb 2021503612
Mar 2021675318
Apr 2021726450
May 2021353114
Jun 2021484822
Jul 2021373720
Aug 2021252521
Sep 2021282714
Oct 2021695433
Nov 2021413519
Dec 2021513910
Jan 2022816813
Feb 2022423113
Mar 20221097950
Apr 2022624974
May 2022886144
Jun 2022998238
Jul 2022795011
Aug 2022694517
Sep 2022483138
Oct 2022594612
Nov 2022392915
Dec 2022356815
Jan 202334269
Feb 2023493213
Mar 2023774836
Apr 2023473651
May 2023665228
Jun 2023605911
Jul 2023776839
Aug 2023725624
Sep 2023615216
Oct 2023746112
Nov 202318811326
Dec 2023998115
Jan 2024712350
Feb 2024362411
Mar 2024514074
Apr 2024513740
Total490042451949